Glucotrack (Nasdaq:GCTK) announced that it appointed Drinda Benjamin as its new vice president of marketing.
Rutherford, New Jersey-based Glucotrack develops an implantable continuous glucose monitor (CGM). It designed its CGM for patients with type 1 and type 2 insulin-dependent diabetes. A recent feasibility study demonstrated reliable glucose measurements for two years post-implant for the device.
Benjamin brings more than 20 years of experience in life sciences to Glucotrack, with focus on commercializing health technology. She has past experiences in product development, strategic marketing and more in the diabetes space. That includes work with blood glucose monitoring, CGM, insulin delivery and closed-loop systems.
Get the full story at our sister site, Drug Delivery Business News.